CovidVax

The updated list of
Covid-19 Vaccines

(including the latest news)
by Current Stageby Distributionby Category
Number of vaccines, at each stage:
still
developing
50+
testing
on animals
58
testing
on humans
42
ready for
distribution
0

Ready for distribution (0)

No vaccine has completed clinical trials yet, but some possible distribution dates have already been announced.

Testing on humans (42)

total people on clinical trials: 325643
vaccine researcher country started people
on trial
Ad26 Janssen (Johnson & Johnson) Belgium + USA Jul 13
2020		 61045
@ Ph. 3
AZD 1222 Jenner Institute (University of Oxford) UK Apr 23
2020		 47432
@ Ph. 3
Ad5-nCoV CanSino Biologics + Beijing Institute of BioTech China + Canada Mar 16
2020		 41108
@ Ph. 3
Adeno-based - Sputnik V Gamaleya Research Institute Russia Jun 17
2020		 40138
@ Ph. 3
mRNA-1273 Moderna + NIAID USA Mar 16
2020		 30755
@ Ph. 3
mRNA BNT162 BioNTech + Pfizer Germany + USA Apr 20
2020		 30189
@ Ph. 2-3
Inactivated Beijing Institute of BioProducts (Sinopharm) China Apr 29
2020		 24448
@ Ph. 3
Inactivated Wuhan Institute of BioProducts (Sinopharm) China Apr 12
2020		 16456
@ Ph. 3
Inactivated Sinovac China + Brazil Apr 13
2020		 12208
@ Ph. 3
NVX-CoV2373 Novavax USA May 6
2020		 12035
@ Ph. 3
Inactivated Institute of Medical Biology + Chinese Academy of Medical Sciences Singapore + China May 15
2020		 1413
@ Ph. 1-2
Inactivated Bharat Biotech India Jul 13
2020		 1125
@ Ph. 1-2
DNA Zydus Cadila India Jul 13
2020		 1048
@ Ph. 1-2
RBD-Dimer Anhui Zhifei Longcom Biopharma + Institute of Microbiology Chinese Academy of Sciences China Jun 22
2020		 1000
@ Ph. 2
mRNA CureVac Germany Jun 17
2020		 859
@ Ph. 2
Protein subunit Instituto Finlay de Vacunas Cuba Aug 24
2020		 676
@ Ph. 1
S protein Sanofi Pasteur + GSK France + UK Sep 3
2020		 440
@ Ph. 1-2
saRNA Imperial College London UK Jun 4
2020		 320
@ Ph. 1
VLP SpyBiotech + Serum Institute of India UK + India Aug 17
2020		 280
@ Ph. 1-2
DNA INO-4800 Inovio Pharma USA + China Apr 3
2020		 280
@ Ph. 1-2
Inactivated Research Institute for Biological Safety Problems Republic of Kazakhstan Kazakhstan Sep 1
2020		 244
@ Ph. 1-2
GX-19 DNA Genexine Inc. + Binex South Korea + Indonesia Jun 17
2020		 190
@ Ph. 1-2a
PD-VLP Medicago Canada Jul 10
2020		 180
@ Ph. 1
RBD Kentucky BioProcessing (British American Tobacco) USA Jul 31
2020		 180
@ Ph. 1-2
mRNA People's Liberation Army Academy of Military Sciences China Jun 25
2020		 168
@ Ph. 1
RBD West China Hospital Sichuan University China Aug 28
2020		 168
@ Ph. 1
Trimeric S protein Clover Biopharma China Jun 19
2020		 150
@ Ph. 1
S protein University of Queensland Australia Jul 14
2020		 120
@ Ph. 1
DNA oral Symvivo Canada Apr 30
2020		 112
@ Ph. 1
aAPC Shenzhen GenoImmune Medical Institute China Feb 15
2020		 100
@ Ph. 1
Peptide FBRI SRC VB VECTOR Russia Jul 27
2020		 100
@ Ph. 1-2
LV-SMENP-DC Shenzhen GenoImmune Medical Institute China Mar 24
2020		 100
@ Ph. 1
Measles Vector Institut Pasteur France + Austria + USA Aug 10
2020		 90
@ Ph. 1
GRAd-COV2 ReiThera + Leukocare Italy + Germany + Belgium Aug 10
2020		 90
@ Ph. 1
mRNA Lunar-Cov19 Arcturus Therapeutics + Duke-NUS USA + Singapore Jul 22
2020		 85
@ Ph. 1-2
S protein Adimmune Taiwan Aug 20
2020		 70
@ Ph. 1
DNA Osaka University + AnGes Japan + USA Jun 29
2020		 60
@ Ph. 1-2
Multitope Peptide-Based Vaccine (MVP); UB-612 Covaxx + University of Nebraska Medical Center (UNMC) USA Sep 1
2020		 60
@ Ph. 1
CpG 1018 Medigen Vaccine Biologics Corp + NIAID Taiwan + USA Sep 01
2020		 45
@ Ph. 1
S protein Vaxine + Flinders University Australia + UK Jun 30
2020		 40
@ Ph. 1
peptides University Hospital Tuebingen Germany Sep 30
2020		 36
@ Ph. 1
DNA BioNet-Asia + Technovalia + Vax4COVID Alliance Thailand + France + Australia
@ Ph. 
Latest updates on these vaccines:
Sep 28COVAXX announced today the first healthy adult volunteers were safely dosed in the company Phase 1 trial in Taiwan
Sep 28Inovio's INO-4800 Phase 2/3 trial has been put on partial clinical hold by U.S. FDA
Sep 25Clover today announced positive preclinical data showing that its vaccine induces a strong immune response against COVID-19
Sep 25J&J released details of its Phase 1/2 data showing its single-dose vaccine can stir up sufficient immune response
Sep 25Endo's subsidiary Par Sterile Products has entered into an agreement with Novavax to produce NVX-CoV2373 final dug product
Sep 24Novavax has started its first Phase 3 study in the UK to evaluate the efficacy and safety of its vaccine
Sep 23Sinovac's vaccine was approved by NMPA for clinical trial in adolescents and children
Sep 23Ad26's Phase 3 study is to assess the efficacy and safety for the prevention of SARS-CoV-2 in adults aged 18+
Sep 23J&J today announced the launch of its large scale multi-country Phase 3 trial for its COVID-19 vaccine
Sep 22Three Government Medical Colleges in Punjab will participate in COVAXIN's Phase 3 trials scheduled to begin Oct. 15

Testing on animals (58)

vaccine researcher country started human
trials
AVI-205 AbVision USA
Unknown Adeleke University Nigeria
AdCOVID intranasal Altimmune + University of Alabama USA Apr
2020		 Q3
2020
Rabies vector Bharat Biotech + Thomas Jefferson University India + USA Apr
2020
mRNA Biocad Russia late Apr
2020
Unknown Catholic University + Millenium Institute of Immunology and Imm.therapy Chile
MVA Centro Nacional Biotecnologia (CNB-CSIC) Spain May
2020
Self amplifying RNA Chimeron Bio + George Madison University's National Center for Biodefense and Infectious Disease USA
mRNA China CDC + Tongji University China Feb
2020
DNA Chula Vaccine Research Center + National Research Council of Thailand Thailand May
2020
exoVACC Codiak BioSciences + Ragon Institute USA
srRNA Elixirgen Therapeutics USA
Unknown Emergex Vaccines + George Mason University's National Center for Biodefense and Infectious Diseases (NCIBD) UK + Canada
Inactivated Erciyes University Turkey May
2020
Recombinant vaccine based on influenza A virus FBRI SRC VB VECTOR Russia
mRNA FBRI SRC VB VECTOR Russia
Subunit FBRI SRC VB VECTOR Russia
Measles Vector FBRI SRC VB VECTOR Russia
VSV Vector FBRI SRC VB VECTOR Russia
Peptide Flow Pharma USA Apr
2020
MVA-VLP GeoVax + BravoVax USA + China Mar
2020		 Q4
2020
AAVCOVID Grousbeck Gene Therapy Center at Mass. Eye and Ear + AveXis USA + Spain May
2020
HSP70 HaloVax USA late Apr
2020
gp-96 Heat Biologics (Zolovax) USA Apr
2020
Dpx-Covid-19 IMV Canada Apr
2020		 Q3
2020
Ad5 ImmunityBio + NantKwest USA
Spike-based Immuno Precise + LiteVax BV Canada + Holland Aug
2020
TaliCoVax19 InnoMedica Switzerland
Intranasal lentiviral vector vaccine Institut Pasteur + TheraVectys France
mRNA Max Planck Institute of Colloids and Interfaces Germany
Protein subunit Max-Planck Institute of Colloids and Interfaces Germany
Attenuated Meissa Vaccines INC USA Jun
2020
Avian IBV oral Migal Research Institute Israel Feb
2020		 Q3
2020
IMT504 NidoVax USA
TerraCoV2 Oragenics (Noachis Terra) + Aragen Bioscience USA
PDS - 0203 PDS Biotech USA
Unknown Precision Vaccines Program at Boston Children's Hospital USA
SK SK Bioscience South Korea Mar
2020		 Sep
2020
RBD Saiba Switzerland Mar
2020		 Aug
2020
Inactivated Selcuk University Turkey
CiVax Soligenix + University of Hawaii at Manoa USA
Recombinant Sorrento Therapeutics USA Mar
2020
S protein St. Petersburg Scientific Research Institute of Vaccines and Serums Russia Mar
2020
DNA Statens Serum Institut Denmark
Linear DNA Takis Biotech + Applied DNA Sciences Italy + USA Apr
2020		 Q4
2020
Unknown United Biomedical (UBI) + c19 Taiwan
Recombinant LVS University of California Los Angeles (Horwitz Lab) USA
PIV5 University of Georgia + University of Iowa USA Apr
2020
skin patch University of Pittsburgh USA Mar
2020		 Jun
2020
Adj Peptide VIDO-InterVac Canada Apr
2020		 Q4
2020
S protein Vabiotech Vietnam May
2020
Nanoparticles (vaults) Vault Pharma + University of California Los Angeles USA
VAAST oral Vaxart USA Apr
2020		 Sep 24
2020
Peptide Vaxil Bio Israel Mar
2020
S protein Verndari + University of California Davis USA Apr
2020
Unknown Vir Biotech + GSK USA + UK
Chimeric vaccine Vivaldi Biosciences + Esco Aster Pte Ltd USA + Singapore
S protein WRAIR + USAMRIID USA Mar
2020
Latest updates on these vaccines:
Sep 14U.S. FDA gave clearance of IND application for Vaxart's vaccine which will start Phase 1 trials this month
Sep 08Vaxart's oral vaccine induced potent systemic and mucosal immune responses in preclinical studies
Sep 01Elixirgen announced that Fujita Health Uni received a contract from AMED to start Phase 1/2 trials
Aug 31WHO has included SelcukUni's vaccine studies in its monitoring list
Aug 28Taiwan's FDA has approved UBI to start clinical trials for its coronavirus vaccine
Aug 26Verndari announced funding from BARDA to support development of Verndari's VaxiPatch technology
Aug 25InstitutPasteurTheraVectys' intranasal vaccine has shown positive results on animals
Aug 24ImmunityBio and NantKwest made an agreement to jointly develop and manufacture vaccines
Aug 13HeatBio's vaccine showed robust T cell driven immune response in preclinical studies
Aug 05Canadian govt will contribute up to CA$4.75m to advance Phase 1 clinical trials of IMV's vaccine

Still in development (50+)

vaccine researcher country animal
trials		 human
trials
S protein AJ Vaccines Denmark
eVLP ARTES Biotech Germany
cVLP AdaptVac (PREVENT-nCoV EU consortium) Denmark + Netherlands + Germany Q4
2020
S1 - Fc AnyGo Technology China
Heat stable subunit Applied Biotech Institute USA
Spike protein Axon Neuroscience Slovakia
S1 or RBD Baylor College of Medicine USA
OMV BiOMVis + University of Trento Italy
intranasal Biocad + IEM Russia
RBD Biological E India
mRNA-LNP CanSino Biologics + Precision Nanosystems China + Canada
RNA Centro Nacional Biotecnologia (CNB-CSIC) Spain
Attenuated Codagenix + Serum Institute of India USA + India Q3
2020
DIOS-CoVax2 DIOSynVax + University of Cambridge UK Jun
2020
Measles Vector DZIF - German Center for Infection Research Germany
MVA-S encoded DZIF - German Center for Infection Research Germany
VLP Doherty Institute Australia
DNA Entos Pharma Canada + USA
S protein EpiVax + University of Georgia USA
VLP Fudan University + Shangai JiaoTong University China
RBD Fudan University + Shangai JiaoTong University China
RNA GeneOne Life Science + Houston Methodist South Korea + USA
Ii-Key peptide Generex + EpiVax Canada + USA
mRNA GreenLight Biosciences USA
AD5 S Greffex USA
VSV IAVI + Batavia + Merck USA
ISR-50 ISR Sweden Q2
2020		 Q4
2020
Plasmid DNA Immunomic Therapeutics + EpiVax USA
VLP Imophoron + Bristol University UK
Attenuated Indian Immunolog. + Griffith University India + Australia
XWG-03 S protein Innovax + Xiamen University Netherlands + China + UK
NDV-SARS-CoV-2/Spike Intravacc + Wageningen Bioveterinary Research Holland
YF17D Vector KU Leuven Belgium
DNA Karolinska Institute (OpenCorona EU project) Sweden + Germany + Italy 2021
Nano particle LakePharma USA
DNA intranasal Mediphage Bioceuticals + University of Waterloo Canada
S protein National Institute of Infectious Disease Japan Japan
RBD-based Neovii + Tel Aviv University Switzerland + Israel
VLP OSIVAX France
S and M proteins OncoGen Romania
VLP Osaka University + BIKEN Japan
Inactivated Osaka University + BIKEN Japan
OMV Quadram Institute Bioscience UK
mRNA RNA immune USA
mRNA Sanofi Pasteur + Translate Bio France + USA
DNA Scancell UK Q1
2021
Inactivated Sinovac + Dynavax China + USA
AD5 S oral Stabilitech UK
APMV The Lancaster University UK UK
TNX-1800 Tonix Pharma USA
S protein UMN Pharma (Shionogi) Japan Q4
2020
Spike based University of Alberta Canada
Plant virus University of California San Diego USA
RBD University of Hong Kong + Xiamen University China Sep 1
2020
Dendritic cell-based University of Manitoba Canada
VLPs University of Sao Paulo Brasil
mRNA University of Tokyo + Daiichi Sankyo Japan
VSV - S University of Western Ontario Canada
M2SR University of Winsconsin + FluGen USA + India Q4
2020
eVLP VBI Vaccines USA + Canada Q4
2020
Inactivated Valneva + Dynavax France + USA Q4
2020
AD + HLA Valo Therapeutics UK
S protein Yisheng Biopharma China
ZIP-1642 Ziphius Therapeutics + Ghent University Belgium
Measles Vector Zydus Cadila India
mRNA intranasal eTheRNA + Epivax Belgium + USA + Canada Q1
2021
Plant produced iBio + CC-Pharming USA + China
Latest updates on these vaccines:
Sep 17Cambridge'sUni vaccine has shown excellent safety and immunogenicity in Phase 1-2 trials
Sep 10HongKongUni's nasal-spray vaccine will have phase 1 clinical trial recruiting about 100 volunteers
Sep 09HKU State Key Lab has partnered with Xiamen Uni and Wantai Biopharmaceutical to rapidly develop a vaccine
Aug 31Daiichi Sankyo was selected by AMED to develop a vaccine
Aug 28Scientists at Nottingham's two leading universities have announced plans to begin clinical trials of Scancell's vaccine in Q1 2021
Aug 26Cambridge's vaccine could start UK clinical trials in Q4 2020 thanks to a £1.9M award from UK govt
Aug 26VBI selected two vaccines candidate to go into Phase 1/2 human study at the end of 2020
Aug 26CambridgeUni has received a £1.9m grant from the UK Gov to conduct clinical trials of its vaccine candidate
Aug 18Therapure Biomanufacturing signed an agreement with VBI Vaccines for vaccine manufacturing
Aug 07Daiichi Sankyo was selected by Japanese Gov. as provider to build production capacity for vaccines


contact | about | ©2020 CovidVax.org project